1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. HALOZYME THERAPEUTICS INC.
Halozyme Therapeutics Inc. XNAS: HALO

Halozyme Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary ...

Read More
60.08 1.03 (1.74%)
40.87% Gain from 52W Low
1.4M
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Halozyme Therapeutics Inc. is on 06 Aug 2025 for the purpose of Halozyme Therapeutics Inc Second Quarter Earnings Results for 2025 See details
Durability score
High Financial Strength
83.3 / 100
Valuation Score
Mid Valuation
41.7 / 100
Momentum Score
Technically Neutral
57.6 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
66
1Yr Price target upside is 10%
9 analysts

16

S

4

W

0

O

3

T

SWOT Analysis

Halozyme Therapeutics Inc. Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..